DCE-MRI perfusion predicts pseudoprogression in metastatic melanoma treated with immunotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DCE-MRI perfusion predicts pseudoprogression in metastatic melanoma treated with immunotherapy
Authors
Keywords
-
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 146, Issue 2, Pages 339-346
Publisher
Springer Science and Business Media LLC
Online
2019-12-24
DOI
10.1007/s11060-019-03379-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?
- (2016) Rovel J. Colaco et al. JOURNAL OF NEUROSURGERY
- MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis
- (2016) Praneil Patel et al. NEURO-ONCOLOGY
- Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI
- (2015) S. Wang et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Diffusion and Perfusion MRI to Differentiate Treatment-Related Changes Including Pseudoprogression from Recurrent Tumors in High-Grade Gliomas with Histopathologic Evidence
- (2015) A.J. Prager et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status
- (2015) J. Arevalo-Perez et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Pseudoprogression and Immune-Related Response in Solid Tumors
- (2015) Victoria L. Chiou et al. JOURNAL OF CLINICAL ONCOLOGY
- Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma
- (2015) Alissa A. Thomas et al. JOURNAL OF NEURO-ONCOLOGY
- Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
- (2015) Hideho Okada et al. LANCET ONCOLOGY
- Response assessment criteria for brain metastases: proposal from the RANO group
- (2015) Nancy U Lin et al. LANCET ONCOLOGY
- Glioma: Application of Histogram Analysis of Pharmacokinetic Parameters from T1-Weighted Dynamic Contrast-Enhanced MR Imaging to Tumor Grading
- (2014) S. C. Jung et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- MRI perfusion in determining pseudoprogression in patients with glioblastoma
- (2012) Robert J. Young et al. CLINICAL IMAGING
- Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases
- (2009) Anna Maria Di Giacomo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- MGMTPromoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients
- (2008) Alba A. Brandes et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started